Sign up
Quantellect · Congress · Trade Detail
NYSE: ABTAbbott Laboratories
RepublicanHouse

Frank A. LoBiondo bought Abbott Laboratories (NYSE: ABT)

Frank A. LoBiondo (R-NJ), a U.S. Representative, has disclosed 2 trades in Abbott Laboratories (ABT) since 2015, all purchases, worth an estimated $16K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a purchase: Frank A. LoBiondo bought $1,001 - $15,000 of Abbott Laboratories (NYSE: ABT) on July 30, 2015. Since that trade, ABT is up +161.25% against the S&P 500 up +313.95%, an outperformance of -152.71%.

Across these filings, Frank A. LoBiondo has been a net buyer of ABT. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

ABT trades
2
Disclosed Vol
$16K
Buys
2
100%
Sells
0
0%
Buy / Sell
All buys
ratio
First → Last
2015

Frank A. LoBiondo's ABT trades vs the price

ABT is up +161.25% since Frank A. LoBiondo bought on July 30, 2015, versus +313.95% for the S&P 500.

Performance since this trade

Price change since trade
+161.25%
S&P 500 change since trade
+313.95%
Outperformance vs S&P 500
-152.71%

All Frank A. LoBiondo ABT trades

TradedTypeSizeReturnEst. profit
July 30, 2015BUY$41.34+161.25%+$9K
July 30, 2015BUY$41.34+161.25%+$9K

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Frank A. LoBiondo & ABT trading FAQ

Is it legal for Frank A. LoBiondo to trade Abbott Laboratories (ABT) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Abbott Laboratories (ABT), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Frank A. LoBiondo buy ABT?

Frank A. LoBiondo disclosed a purchase of $1,001 - $15,000 of Abbott Laboratories (ABT) on July 30, 2015, according to public STOCK Act filings.

How has ABT performed since Frank A. LoBiondo's trade?

Since Frank A. LoBiondo bought ABT on July 30, 2015, the stock is up +161.25%, versus +313.95% for the S&P 500 over the same period, an outperformance of -152.71%.

How many times has Frank A. LoBiondo traded ABT?

Frank A. LoBiondo has disclosed 2 ABT trades since 2015. Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional ABT trades?

Quantellect tracks every disclosed congressional trade in Abbott Laboratories (ABT) on the Abbott Laboratories congressional trading page, which aggregates filings across all members of Congress.

Frank A. LoBiondo's ABT tradesAll congressional filings for Abbott LaboratoriesFrank A. LoBiondo's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.